AS2TS intermediate model information! 

MOLECULE  1c5g_A  
HEADER    BLOOD CLOTTING                          07-DEC-99   1C5G               
TITLE     PLASMINOGEN ACTIVATOR INHIBITOR-1                                      
COMPND    MOL_ID: 1;                                                             
COMPND   2 MOLECULE: PLASMINOGEN ACTIVATOR INHIBITOR-1;                          
COMPND   3 CHAIN: A;                                                             
COMPND   4 SYNONYM: PAI-1;                                                       
COMPND   5 ENGINEERED: YES;                                                      
COMPND   6 OTHER_DETAILS: LATENT FORM                                            
SOURCE    MOL_ID: 1;                                                             
SOURCE   2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;                                    
SOURCE   3 ORGANISM_COMMON: HUMAN;                                               
SOURCE   4 ORGANISM_TAXID: 9606;                                                 
SOURCE   5 EXPRESSION_SYSTEM: ESCHERICHIA COLI;                                  
SOURCE   6 EXPRESSION_SYSTEM_TAXID: 562;                                         
SOURCE   7 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID;                               
SOURCE   8 EXPRESSION_SYSTEM_PLASMID: PPAIST-7HS                                 
KEYWDS    SERPIN, SERINE PROTEASE INHIBITOR, PLASMA, PLASMINOGEN ACTIVATION,     
KEYWDS   2 GLYCOPROTEIN, POLYMORPHISM, BLOOD CLOTTING                            
EXPDTA    X-RAY DIFFRACTION                                                      
AUTHOR    E.J.GOLDSMITH                                                          
REVDAT   4   27-DEC-23 1C5G    1       REMARK                                    
REVDAT   3   24-FEB-09 1C5G    1       VERSN                                     
REVDAT   2   01-APR-03 1C5G    1       JRNL                                      
REVDAT   1   17-DEC-99 1C5G    0                                                 
JRNL        AUTH   H.M.TUCKER,J.MOTTONEN,E.J.GOLDSMITH,R.D.GERARD                
JRNL        TITL   ENGINEERING OF PLASMINOGEN ACTIVATOR INHIBITOR-1 TO REDUCE    
JRNL        TITL 2 THE RATE OF LATENCY TRANSITION.                               
JRNL        REF    NAT.STRUCT.BIOL.              V.   2   442 1995               
JRNL        REFN                   ISSN 1072-8368                                
JRNL        PMID   7664104                                                       
JRNL        DOI    10.1038/NSB0695-442                                           
REMARK   2 RESOLUTION.    2.60 ANGSTROMS.                                        
DBREF  1C5G A    1   402  UNP    P05121   PAI1_HUMAN       1    402              
SEQRES   1 A  402  MET GLN MET SER PRO ALA LEU THR CYS LEU VAL LEU GLY           
SEQRES   2 A  402  LEU ALA LEU VAL PHE GLY GLU GLY SER ALA VAL HIS HIS           
SEQRES   3 A  402  PRO PRO SER TYR VAL ALA HIS LEU ALA SER ASP PHE GLY           
SEQRES   4 A  402  VAL ARG VAL PHE GLN GLN VAL ALA GLN ALA SER LYS ASP           
SEQRES   5 A  402  ARG ASN VAL VAL PHE SER PRO TYR GLY VAL ALA SER VAL           
SEQRES   6 A  402  LEU ALA MET LEU GLN LEU THR THR GLY GLY GLU THR GLN           
SEQRES   7 A  402  GLN GLN ILE GLN ALA ALA MET GLY PHE LYS ILE ASP ASP           
SEQRES   8 A  402  LYS GLY MET ALA PRO ALA LEU ARG HIS LEU TYR LYS GLU           
SEQRES   9 A  402  LEU MET GLY PRO TRP ASN LYS ASP GLU ILE SER THR THR           
SEQRES  10 A  402  ASP ALA ILE PHE VAL GLN ARG ASP LEU LYS LEU VAL GLN           
SEQRES  11 A  402  GLY PHE MET PRO HIS PHE PHE ARG LEU PHE ARG SER THR           
SEQRES  12 A  402  VAL LYS GLN VAL ASP PHE SER GLU VAL GLU ARG ALA ARG           
SEQRES  13 A  402  PHE ILE ILE ASN ASP TRP VAL LYS THR HIS THR LYS GLY           
SEQRES  14 A  402  MET ILE SER ASN LEU LEU GLY LYS GLY ALA VAL ASP GLN           
SEQRES  15 A  402  LEU THR ARG LEU VAL LEU VAL ASN ALA LEU TYR PHE ASN           
SEQRES  16 A  402  GLY GLN TRP LYS THR PRO PHE PRO ASP SER SER THR HIS           
SEQRES  17 A  402  ARG ARG LEU PHE HIS LYS SER ASP GLY SER THR VAL SER           
SEQRES  18 A  402  VAL PRO MET MET ALA GLN THR ASN LYS PHE ASN TYR THR           
SEQRES  19 A  402  GLU PHE THR THR PRO ASP GLY HIS TYR TYR ASP ILE LEU           
SEQRES  20 A  402  GLU LEU PRO TYR HIS GLY ASP THR LEU SER MET PHE ILE           
SEQRES  21 A  402  ALA ALA PRO TYR GLU LYS GLU VAL PRO LEU SER ALA LEU           
SEQRES  22 A  402  THR ASN ILE LEU SER ALA GLN LEU ILE SER HIS TRP LYS           
SEQRES  23 A  402  GLY ASN MET THR ARG LEU PRO ARG LEU LEU VAL LEU PRO           
SEQRES  24 A  402  LYS PHE SER LEU GLU THR GLU VAL ASP LEU ARG LYS PRO           
SEQRES  25 A  402  LEU GLU ASN LEU GLY MET THR ASP MET PHE ARG GLN PHE           
SEQRES  26 A  402  GLN ALA ASP PHE THR SER LEU SER ASP GLN GLU PRO LEU           
SEQRES  27 A  402  HIS VAL ALA GLN ALA LEU GLN LYS VAL LYS ILE GLU VAL           
SEQRES  28 A  402  ASN GLU SER GLY THR VAL ALA SER SER SER THR ALA VAL           
SEQRES  29 A  402  ILE VAL SER ALA ARG MET ALA PRO GLU GLU ILE ILE MET           
SEQRES  30 A  402  ASP ARG PRO PHE LEU PHE VAL VAL ARG HIS ASN PRO THR           
SEQRES  31 A  402  GLY THR VAL LEU PHE MET GLY GLN VAL MET GLU PRO               
CRYST1  157.590   47.840   62.880  90.00 107.78  90.00 C 1 2 1       4           
END  

FATAL: There is no PDB entry  ( 1c5g_A ) in the database!